The infectious complications of bronchial cancer;Les complications infectieuses du cancer bronchique

Revue des Maladies Respiratoires

Volumn 15, Issue 4, 1998, Pages 451-459

  Klastersky, J ^a,b  

^a JULES BORDET INSTITUTE   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Antibiotics; Bronchial cancer; Chemoprophylaxis; Chemotherapy; Growth factors; Infection

Indexed keywords

ANTIBIOTIC PROPHYLAXIS; BRONCHUS CANCER; FEVER; HUMAN; INFECTION RISK; NEUTROPENIA; REVIEW;

ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; LUNG NEOPLASMS; NEUTROPENIA; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0031714110     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. BRAMBILLA C, ROMAND Ph, VANDERKERCKOVE C, MORO D : Infection respiratoire et cancer bronchique. Rev Mal Respir 1992;9:R49-R52.
2. PERLIN E, BANG KM, KASSIM OO : The impact of pulmonary infections on the survival of lung cancer patients. Cancer 1960;66:593-6.
3. NAGATA N, NIKAIDO Y, KIDO M, ISHIBASHI T, SUCISHI K : Terminal pulmonary infections in patients with lung cancer. Chest 1993;103:1739-42.
4. PUTINATI S, TREVIANI L, GUALANDI M et al. : Pulmonary infections in lung cancer patients at diagnosis. Lung Cancer 1994;11:243-9.
5. HANSEN SW, AABO K, OSTERLIND K : Lung abscess in small cell carcinoma of the lung during chemotherapy and corticosteroids : an analysis of 276 consecutive patients. Eur J Respir Dis 1986;68:7-11.
6. VAN HOUTTE C, GREGOR A, PHILIPS P : International survey of radiotherapy practice for radical treatment of non-small cell lung cancer. Lung Cancer 1994;11:(Suppl. 3) : S129-S138.
7. MARKMAN M, ABELOFF MD : Management of hematologic and infectious complications of intensive induction therapy of small cell carcinoma of the lung. Am J Med 1983;74:741-6.
8. SICKLES EA, GREENE WH, WIERNIK PH : Clinical presentation of infections in granulocytopenic patients. Arch Intern Med 1975;175:715-9.
9. BERNARD C, MOMBELLI G, KLASTERS J : Pneumococcal bacteremia in patients with neoplasic diseases. Ear J Cancer Clin Oncol 1981;17:1041-6.
10. RICHARD V, MEUNIER F, VAN DER AUWERA P, DEJACE P, DANEAU D, KLASTERSKY J : Pneumococcal bacteremia in cancer patients. Eur J Epidemiol 1988;4:242-5.
11. KLASTERSKY J, MOMMEN P, CANTRAINE F, SAFARYS A: Placebo controlled pneumococcal immunization in patients with bronchogenic carcinoma. Eur J Cancer Clin Oncol 1986;22:807-13.
12. HUGHES WT, KUHN S, CHAUDARY S et al. : Successful chemoprophylaxis of Pneumocystis carinii pneumonitis. N Engl J Med 1977;297;1419-26.
13. DE JONGH CA, WADE JC, FINLEY RS et al. : Trimethoprim/sulfamethoxazole versus placebo : a double-blind comparison of infection prophylaxis in patients with small cell carcinoma of the lung. J Clin Oncol 1983;1:302-7.
14. FIGUEREDO AT, HRYNIUK WM, STRAUTMANIS I, FRANK G, RENDELL S : Cotrimoxazole prophylaxis during high-dose chemotherapy of small-cell lung cancer. J Clin Oncol 1985;3:54-64.
15. EORTC : International Antimicrobial Therapy Project Group, Trimethoprim-sulfamethoxazole in the prevention of infection in neutropenic patients. J Infect Dis 1984;150:372-9.
16. KLASTERSKY J : Chemoprophylaxis of Gram-negative infections in neutropenic patients. Eur Urol 1990;17;40-5.
17. SCHIMPFF SC, SATTERLEE W, YOUNG MW et al. : Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med 1971; 13:1061-6.
18. EORTC : International Antimicrobial Therapy Cooperative Group, Ceftazidime combined with a short or long course of amikacin for empirical therapy of Gram-negative bacteremia in cancer patients with granulocytopenia. Af Engl J Med 1987;317:1692-8.
19. Pizzo PA, HARTHORN JW, HIEMENZ J et al. : A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. N Engl J Med 1986;315:552-8.
20. WINSTON DJ, Ho WG, BRUCKNER DA et al. : Beta-lactam antibiotic therapy in febrile granulocytopenic patients. Ann Intern Med 1991;115:849-59.
21. MATSI K, MASUDA N, TAKADA M, KUSUNOKI Y, FUKUOKA M : A randomized trial comparing imipenem/cisplatine alone with latamoxef plus tobramycin in febrile neutropenic patients with lung cancer. J Clin Oncol 1991;27:428-34.
22. KLASTERSKY J : Febrile neutropenia. Curr Opin Oncol 1993;5:625-32.
23. EORTC and National Cancer Institute of Canada, Vancomycin added to empirical combination antibiotic therapy for lever in granulocytopenic cancer patients. J Infect Dis 1991; 193:951-81.
24. ATTALI M, SCHLAIFER D, RUBIE H et al : Prevention of Gram-positive infections after bone marrow transplantation by systemic vancomycin : a prospective, randomized trial. J Clin Oncol 1991;9;865-70.
25. SCULIER JP, KLASTERSKY J, STRYCKMANS P, and the EORTC Lung Cancer Working Party, Late intensification in small-cell lung cancer : a phase I study of high doses of cyclo-phosphamide and etoposide with autologous bone marrow transplantation. J Clin Oncol 1985;3:184-91.
26. CRAWFORD J, OZER H, STOLLER R et al : Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 1991;325:167-70.
27. OSHITA F, TAMURA T, OKAMOTO H et al. : The frequency and management of infectious episodes and sepsis in small cell lung cancer patients receiving intensive chemotherapy with granulocyte-colony stimuating factor. J Clin Oncol 1991;21:-353-9.
28. GURNEY H, ANDERSON H, RADFORD et al. : Infection risk in patients with small cell lung cancer receiving intensive chemotherapy and recombinant human granulocyte-macrophage colony-stimulating factor. Eur J Cancer 1992;28:105-12.
29. IHDE DC, MULSHINE JL, KRAMER BS et al. : Randomized trial of high vs. standard dose of etoposide (VP16) and cisplatin in extensive stage small cell lung cancer (SCLC). Proc Am Soc Clin Oncol 1991;10:240 abstract no 819.
30. JOHNSON DH, EINHORN LH, BIRCH R et al. : A randomized comparison of high-dose versus conventionnal-dose cyclo-phosphamide, doxorubin and vincristine for extensive-stage small-cell lung cancer : a phase III trial of the Southeastern Cancer Study Group. J Clin Oncol 1987;5:1731-8.
31. ABELOFF MD, KLASTERSKY J, DRINGS PD et al. : Complications of treatment of small cell carcinoma of the lung. Cancer Treat Rep 1983;67:21-6.